FDA Inspection 993103 — Roche Diagnostics GmbH
The FDA completed an inspection of Roche Diagnostics GmbH on November 18, 2016 in Mannheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2016
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Mannheim (Germany)
Additional Details
Postmarket Audit Inspections